Equities

Kilitch Drugs (India) Ltd

KILITCH:NSI

Kilitch Drugs (India) Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)367.45
  • Today's Change-2.55 / -0.69%
  • Shares traded25.65k
  • 1 Year change+62.59%
  • Beta0.9489
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue1,5441,3961,142
OPERATING EXPENSES
Cost of revenue total968907750
Selling, general and admin. expenses, total303303226
Depreciation/amortization333625
Unusual expense(income)------
Other operating expenses, total291055
Total operating expense1,3341,2561,056
Operating income21014086
Other, net5.055.852.62
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes19412096
Provision for income taxes583734
Net income after taxes1368362
Minority interest102212
Net income before extra. Items14610474
Total extraordinary items------
Net income14610474
Inc.avail. to common excl. extra. Items14610474
Inc.avail. to common incl. extra. Items14610474
EPS RECONCILIATION
Basic/primary weighted average shares161616
Basic/primary eps excl. extra items9.176.714.73
Basic/primary eps incl. extra items9.176.714.73
Dilution adjustment------
Diluted weighted average shares161616
Diluted eps excl. extra items9.176.714.73
Diluted eps incl. extra items9.176.714.73
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental5949--
SUPPLEMENTAL INCOME
Depreciation, supplemental242716
Total special items8.438.438.43
NORMALISED INCOME
Normalized income before taxes202129105
Effect of special items on income taxes000
Income tax excluding impact of special items583734
Normalized income after tax1449171
Normalized income avail. to common15411382
Basic normalized EPS9.707.255.27
Diluted normalized EPS9.707.255.27
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.